pharma
#drug discovery
pharma
After 37 Years, Ionis' Founding Scientist Frank Bennett Is Stepping Away
pharma
Bristol Myers Squibb Buys Nvidia's Vera Rubin to Speed Up Drug Discovery
pharma
Bristol Myers Squibb Doubles Down on NVIDIA to Supercharge Drug Discovery
pharma
Insilico and Bora Bet $2.5B on AI-Run Drug Factories
pharma
Generative AI Jumps From Drug Discovery to the Factory Floor in $2.5B Bora Deal
pharma
Insilico Medicine Tops $100M Revenue and Teams With Bora on AI Manufacturing
pharma
Hong Kong's First AI Pharma Stock Swings to Profit as Revenue Jumps 272%
pharma
Insilico and CMS Deepen AI Drug Push With Brain-Disease Deal Worth Up to $2.5bn
pharma
Mindbeam Turns Generative AI Loose on the Hunt for Safer Painkillers
pharma
Insilico Medicine and Eli Lilly Take Lead Roles at Harvard's 13th ARDD Meeting
pharma
Takeda Taps Insilico Medicine's Pharma.AI to Hunt for New Drugs
pharma
AI Cracks How Drugs Latch Onto Proteins
tech
Indian Startups Bet on Quantum Computing to Speed Up Drug Discovery
pharma
Recursion's AI Drug Bet Hasn't Won Over the Stock Market
pharma
Insilico Medicine to Spotlight AI Drug Discovery at Geneva's AI for Good Summit
pharma
Capgemini Says AI Is Reshaping the Hunt for New Drugs
pharma
Anthropic Takes On Drug Discovery for Diseases Big Pharma Won't Touch
pharma
Takeda Bets Up to $600M on Insilico's AI to Hunt New Drugs
pharma
Anthropic Wants to Make Its Own Drugs, With Claude as the Chemist
pharma
Takeda Bets on AI, Signs Drug Discovery Deal With Insilico Worth Up to $600 Million
pharma
Takeda Bets Up to $600M on Insilico's AI to Hunt for New Drugs
pharma
AI Reshapes Pharma From the Lab Bench to the Packaging Line
pharma
Anthropic Launches Claude Science, Betting on AI-Powered Drug Discovery
pharma
Anthropic Steps Into Drug Discovery With New Claude Science Platform
pharma
India's Mankind Pharma Bets on AI to Speed Up Drug Discovery
pharma
Anthropic Bets Big on Drug Discovery With New 'Claude Science' Platform
pharma
AI Moves From Buzzword to Deal-Maker in Drug Discovery
pharma
AI Is Compressing Drug Discovery From Years to Weeks
pharma
Bayer Turns to AI to Speed Up Its Hunt for New Drugs
pharma
AI Is Reshaping the Drug Pipeline, From Eli Lilly to Tempus
pharma
NVIDIA's BioNeMo Turns AI Models Into Plug-In Skills for Drug Hunters
pharma
Metsera's Founders Bet on an 'AI Scientist' to Spin Up New Biotechs
pharma
Insilico and SK Bet Up to $2.5B on AI-Designed Neuroimmune Drugs
pharma
Nvidia Doubles Down on AI Drug Discovery With Recursion Bet
pharma
Boehringer Bets $15M on Immunai's AI to Hunt Cancer Drug Targets
pharma
Insilico's AI Bet: Be No. 1 in China, Build a 'God Drug' for Longevity
pharma
SandboxAQ and NVIDIA Team Up on AI Tool to Speed Drug Discovery
pharma
Nvidia's New BioNeMo Toolkit Turns AI Agents Into Drug-Discovery Lab Helpers
pharma
Insilico and SK Biopharmaceuticals Forge AI Drug-Discovery Deal Worth Up to 2.5 Billion
pharma
Insilico Inks AI Drug Discovery Pact Worth Up to $2.5 Billion
pharma
UCLA Unveils AI Platform to Speed the Hunt for Cancer Therapies
pharma
Bayer Turns to Iambic's AI Platform in New Drug Discovery Push
pharma
Insilico and SK Bet Up to $2.5 Billion on AI-Designed Brain Drugs
pharma
Eli Lilly and Nvidia Team Up to Build Pharma's Most Powerful AI Supercomputer
pharma
AI Drug Discovery Splits Into Two Camps: Eli Lilly vs. Twist Bioscience
pharma
AI's Next Act in Medicine Could Mint a New Class of Millionaires
ai
OpenAI's New Science Test Stumps AI: Just 1 in 3 Research Tasks Passed
pharma
Boltz Signs AI Drug Discovery Deal With Pharma Giant Takeda
pharma
Axcelead Joins Eli Lilly's TuneLab to Speed AI Drug Discovery
pharma
LG Chem Teams Up With UK's LabGenius to Hunt Cancer Drugs Using AI
pharma
Merck Bets Up to $510M on AI Drug Discovery With Protillion
pharma
LG's AI Lab Teams Up With D&D Pharmatech to Design Peptide Drugs
pharma
South Korea's JW Pharmaceutical Bets on AI and Robots to Crack Cancer Drugs Faster
pharma
AI Drug Discovery's Real Bottleneck? It's the Biology Data, Not the AI
pharma
Merck Bets on AI Drug Design With Protillion Biosciences Deal
pharma
AI Could Boost Indian Pharma Margins by Up to 4 Percentage Points, Bernstein Says
pharma
Insilico Medicine Launches 'Bits to Bio' Series on AI-Drug Discovery
pharma
Radical Numerics Emerges With $50M to Crack the Code of Life Using AI
pharma
OpenAI's GPT-Rosalind Brings AI Into the Drug Discovery Lab
pharma
The AI Drug Revolution Has Its First Named Molecule — But the Hard Part Is Still Ahead
pharma
Bayer and Peking University Sign Their Fifth Drug Discovery Deal
pharma
Novo Nordisk Bets on OpenAI to Reshape Drug Discovery and the Factory Floor
pharma